CartiHeal's Agili-C™ Implant Promotes the Regenerative Capacity of Articular Cartilage Defects in Human Cadaveric Ex-vivo Model - iData Research
Innovador implante de rodilla inventado en Israel utilizado por primera vez
Agili-C implant promotes the regenerative capacity of articular cartilage defects in an ex vivo model | SpringerLink
Orthopaedic regenerative tissue engineering en route to the holy grail: disequilibrium between the demand and the supply in the operating room | Journal of Experimental Orthopaedics | Full Text
Agili-C – P210034 | FDA
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
JNJ Leads $15 Million Funding for Innovative Cartilage Technology | Orthopedics This Week